financetom
Business
financetom
/
Business
/
What's Going On With Children's Place Stock After Q2 Earnings?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Children's Place Stock After Q2 Earnings?
Sep 11, 2024 10:30 AM

Children’s Place, Inc. shares are soaring Wednesday after the company posted a second-quarter earnings beat before the opening bell.

The Details:

Children’s Place reported quarterly earnings of 30 cents per share which beat the analyst consensus estimate of losses of $1.10 per share.  

The company reported quarterly sales of $319.655 million, below the consensus estimate of $327.38 million. Children's Place said the decrease in net sales was primarily driven by an anticipated decrease in ecommerce revenue, as the company proactively rationalized its unprofitable promotional strategies, inflated marketing spend and “free shipping” offers to significantly improve profitability. 

The company said the cost-cutting measures improved the profitability of its ecommerce business and also benefited its brick-and-mortar channel.

Stores experienced a positive comparable store sales result for the first time since 2021, driven by stronger units per transaction and conversion metrics, and improving traffic trends. Wholesale business also rebounded with double-digit growth after a decline in the first quarter.

Read Next: What’s Going On With Palantir Stock?

“During the second quarter we proactively made certain strategic and operational changes to improve the profitability of the business and provide a foundation for future growth and we were pleased with the results. While we anticipated that these efforts would provide pressure to topline sales, we drove significant improvements in gross profit margin versus the prior year’s second quarter and sequential improvement in margin for two quarters, which is particularly important moving from the first quarter to the second quarter," said Muhammad Umair, President and Interim CEO. 

Children's Place shares are moving higher on heavy trading volume following the print. Trading was halted for volatility just after the opening bell, and more than 22 million shares have already changed hands in Wednesday's session, according to the latest data from Benzinga Pro.

PLCE Price Action: According to Benzinga Pro, Children's Place shares are up 88.6% at $9.24 at the time of publication Wednesday.

Read Also:

What’s Going On With AMD Stock Today?

Image: Michal Jarmoluk from Pixabay

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copper output from Chile's Codelco down 6% in April
Copper output from Chile's Codelco down 6% in April
Jun 7, 2024
SANTIAGO, June 7 (Reuters) - Copper production from Chile's state-run miner Codelco, the world's largest producer of the metal, dropped 6.1% in April compared to the same month last year to total 95,100 metric tons, data from copper commission Cochilco showed on Friday. Copper output also fell during the month at Chile's Escondida mine, though it edged up 1.9% in...
Arcturus Therapeutics Prospective Cystic Fibrosis Treatment Shows Positive Results -- Shares Tumble
Arcturus Therapeutics Prospective Cystic Fibrosis Treatment Shows Positive Results -- Shares Tumble
Jun 7, 2024
03:16 PM EDT, 06/07/2024 (MT Newswires) -- Arcturus Therapeutics ( ARCT ) slumped more than 29% in Friday trading, despite reporting positive preliminary data from phase 1 and phase 1b study of its ARCT-032 prospective treatment for cystic fibrosis. Appearing at an industry conference in Glasgow, Scotland, executives of the the messenger RNA medicines and vaccines company said the inhaled...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Jun 7, 2024
(Reuters) - A 15-day course of Pfizer's ( PFE ) COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, there are no proven treatments specifically for long COVID in which a host of symptoms can last for many months after initial coronavirus infection. Scientists and patients had hoped that Pfizer's...
Chemed Insider Sold Shares Worth $816,255, According to a Recent SEC Filing
Chemed Insider Sold Shares Worth $816,255, According to a Recent SEC Filing
Jun 7, 2024
03:16 PM EDT, 06/07/2024 (MT Newswires) -- Kevin J McNamara, Director, President and CEO, on June 06, 2024, sold 1,500 shares in Chemed ( CHE ) for $816,255. Following the Form 4 filing with the SEC, McNamara has control over a total of 107,049 shares of the company, with 107,049 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/19584/000095017024070509/xslF345X03/ownership.xml Price: 544.96, Change: +0.79,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved